Kenvue India presents report on ‘The Hydration Gap for Non-Diarrheal Illnesses’
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
This facility marks a significant milestone in transforming the global food industr
Merck has also decided to end the favezelimab clinical development program
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Demonstrates vision gains with extended treatment intervals in retinal vein occlusion
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
Subscribe To Our Newsletter & Stay Updated